Pharmacoeconomic Evaluation of Using One-Molar Gadolinium-Based Magnetic Resonance Contrast Agent Compared to Half-Molar Agents for the Diagnosis of Multiple Sclerosis
Objective: to conduct a comparative assessment of the pharmacoeconomic advantages of using gadobutrol in comparison with half-molar (0.5 M) gadolinium chelates for the diagnosis of multiple sclerosis (MS).Material and methods. A calculator was developed in Microsoft Excel, in which the number of exa...
Saved in:
| Main Authors: | A. A. Alikhanov, N. L. Shimanovskiy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Luchevaya Diagnostika, LLC
2020-11-01
|
| Series: | Вестник рентгенологии и радиологии |
| Subjects: | |
| Online Access: | https://www.russianradiology.ru/jour/article/view/594 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE DIAGNOSTIC EFFICACY AND SAFETY OF MACROCYCLIC GADOLINIUM-BASED MAGNETIC RESONANCE CONTRAST AGENTS
by: V. O. Panov, et al.
Published: (2017-07-01) -
Нas the stability of gadoliniumbased magnetic resonance contrast media the clinical significance?
by: V. O. Panov, et al.
Published: (2016-09-01) -
Pharmacoeconomic Study on the Application of Magnetic Resonance Imaging with Gadoxetic Acid in Addition to Contrast-Enhanced Computed Tomography in Diagnosis of Hepatocellular Carcinoma
by: G. G. Kаrmаzаnovsky, et al.
Published: (2021-11-01) -
Comparison of gadobutrol and meglumine gadoterate for dynamic contrast-enhanced MRI of pituitary macroadenomas
by: Kihwan Hwang, et al.
Published: (2025-07-01) -
Electrochemical Method for the Design of New Possible Gadolinium-Based Contrast Agents
by: Claudia Carbone, et al.
Published: (2024-12-01)